Cross-posted at RHRealityCheck.org
President Obama has repeatedly stressed his administration’s commitment to science as one way to distinguish his leadership from that of his predecessor. Right now that commitment is being put to the test on HIV and AIDS: if the President could do more to end the crisis, would he?
A revolutionized response to the global AIDS crisis has just been made possible with the August publication of a US-funded study showing that antiretroviral AIDS medicines (ARVs) can cut the risk of HIV transmission from an infected to a non-infected partner by 96 percent. Not only do AIDS drugs save lives—they are among the most powerfully effective prevention tools.
This double-benefit changes the equation in fighting AIDS at home and abroad and raises the question: Will the Obama administration respond?
That is why we are launching The 96% Campaign making clear the choice the President faces between action and inaction. AIDS treatment is not just science—it’s a reproductive, economic, and racial justice issue.